Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 244 Lung Neoplasms 77 Melanoma 57 Carcinoma, Renal Cell 44 Small Cell Lung Carcinoma 33 Colorectal Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 24 Carcinoma, Transitional Cell 24 Neoplasms 23 Triple Negative Breast Neoplasms 22 Neoplasm Metastasis 21 Carcinoma, Hepatocellular 19 Ovarian Neoplasms 17 Mesothelioma 17 Pancreatic Neoplasms 15 Mesothelioma, Malignant 15 Stomach Neoplasms 13 Breast Neoplasms 13 Uterine Cervical Neoplasms 12 Urinary Bladder Neoplasms 10 Head and Neck Neoplasms 10 Carcinoma, Merkel Cell 10 Kidney Neoplasms 9 Adenocarcinoma of Lung 8 Esophageal Neoplasms 7 Endometrial Neoplasms 7 Lymphoma 6 Carcinoma, Squamous Cell 6 Brain Neoplasms 6 Prostatic Neoplasms 5

Interventions

Paclitaxel 3 Carboplatin 3 tremelimumab 1 pembrolizumab 1 necitumumab 1 envafolimab 1 durvalumab 1 anlotinib 1 Nivolumab 1 Gemcitabine 1 Endostatins 1 Drug Therapy 1 Cisplatin 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Squamous Non-small Cell Lung Cancer × Nivolumab × Thoracic × Clear all

NCT03542461 2022-10-03

EDEN

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Unknown

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡